scanning capabilities that can be customized for each interventional application. TherVoyant has recognized key barriers that have constrained the clinical adoption of MRI-guided procedures. Currently, device companies rely on MRI manufacturers to implement the imaging features and software interfaces needed to guide the MRI-compatible devices. However, the manufacturers typically take years to implement new features. For low-prevalence conditions, the features may never be placed into the standard software release. Using the Apps-based approach, TherVoyant can implement a workflow for a new procedure within a few weeks. TherVoyant’s flagship product, GuideRT, is a technology platform that provides an Apps-based workflow interface to interactively guide surgical procedures with immediate feedback using Real-Time MRI in the areas of neurosurgery, oncology procedures and new drug therapies. With GuideRT, surgeons and healthcare providers can significantly improve surgical procedures, reduce surgical time and improve the lives of their patients.